About Epoxide hydrolase 1
Epoxide hydrolase 1 (EPHX1) is a protein
from Homo sapiens identified by UniProt accession
P07099, 455 residues long.
MolForge cross-references it against 0 known binders and
257 disease associations.
Target properties
| Protein name | Epoxide hydrolase 1 |
| UniProt accession | P07099 |
| Gene | EPHX1 |
| Organism | Homo sapiens |
| Length | 455 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (257)
Diseases linked to this target (Open Targets).
- sex hormone-binding globulin measurement · score 0.37
- Insulin resistance · score 0.37
- insulin resistance · score 0.37
- Lipodystrophy · score 0.37
- hypercholanemia, familial · score 0.37
- lipodystrophy · score 0.37
- cystic fibrosis · score 0.19
- glioblastoma multiforme · score 0.16
- appendicular lean mass · score 0.12
- hypercholanemia, familial 1 · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P07099-F1 | alphafold | PREDICTED | 95.12 | — |
Amino-acid sequence (455 residues)
MWLEILLTSV LGFAIYWFIS RDKEETLPLE DGWWGPGTRS AAREDDSIRP FKVETSDEEI HDLHQRIDKF RFTPPLEDSC FHYGFNSNYL KKVISYWRNE FDWKKQVEIL NRYPHFKTKI EGLDIHFIHV KPPQLPAGHT PKPLLMVHGW PGSFYEFYKI IPLLTDPKNH GLSDEHVFEV ICPSIPGYGF SEASSKKGFN SVATARIFYK LMLRLGFQEF YIQGGDWGSL ICTNMAQLVP SHVKGLHLNM ALVLSNFSTL TLLLGQRFGR FLGLTERDVE LLYPVKEKVF YSLMRESGYM HIQCTKPDTV GSALNDSPVG LAAYILEKFS TWTNTEFRYL EDGGLERKFS LDDLLTNVML YWTTGTIISS QRFYKENLGQ GWMTQKHERM KVYVPTGFSA FPFELLHTPE KWVRFKYPKL ISYSYMVRGG HFAAFEEPEL LAQDIRKFLS VLERQ
Explore Epoxide hydrolase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets